Published in:
01-10-2017 | Erratum
Erratum to: Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy
Published in: International Journal of Clinical Oncology | Issue 5/2017
Login to get accessExcerpt
In the original publication of the article, there were incorrect values in Tables 3, 4 and supplementary Tables S3 and S4.
Table 3
Univariable and multivariable analysis of clinical factors and mortality in all patients
|
Clinical factors
|
Morbidity
|
Liver-related morbidity
|
Mortality
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Univariable analysis
|
Multivariable analysis
|
Univariable analysis
|
Multivariable analysis
|
Univariable analysis
|
Multivariable analysis
|
|||||||
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
|
|
Age ≥65 years
|
1.56 (0.76, 3.26)
|
0.23
|
2.55 (0.7, 12)
|
0.16
|
1.77 (0.35, 2.83)
|
0.213
|
||||||
|
Sex Male
|
1.23 (0.56, 1.66)
|
0.46
|
1.33 (0.74, 2.67)
|
0.57
|
1.45 (0.41, 2.43)
|
0.368
|
||||||
|
Sarcopenia
|
1.22 (0.60, 2.51)
|
0.58
|
2.88 (0.79, 13.6)
|
0.11
|
7.77 (1.93, 14.9)
|
0.021
|
8.2 (1.12, 17.2)
|
0.038
|
||||
|
Body mass index ≤22.5 kg/m²
|
0.94 (0.46, 1.91)
|
0.86
|
0.82 (0.23, 2.85)
|
0.75
|
0.53 (0.58, 1.72)
|
0.46
|
||||||
|
Low visceral fat amount
|
0.78 (0.37, 1.61)
|
0.5
|
0.93 (0.26, 3.23)
|
0.9
|
0.80 (0.52, 1.94)
|
0.37
|
||||||
|
Albumin ≥4 g/dl
|
0.48 (0.21, 1.03)
|
0.06
|
0.566 (0.12, 2.14)
|
0.41
|
0.82 (0.16, 3.47)
|
0.78
|
||||||
|
Total bilirubin ≥0.7 mg/dl
|
0.57 (0.25, 1.23)
|
0.15
|
0.65 (0.13, 2.45)
|
0.53
|
0.75 (0.5, 2.0)
|
0.39
|
||||||
|
Platelet count ≥16.8 × 104/μl
|
1.02 (0.49, 2.15)
|
0.95
|
2.53 (0.67, 12.2)
|
0.17
|
2.29 (0.31, 3.25)
|
0.13
|
||||||
|
ICGR15 ≥10.7%
|
0.57 (0.27, 1.21)
|
0.144
|
0.66 (0.16, 2.41)
|
0.53
|
0.51 (0.59, 1.69)
|
0.477
|
||||||
|
HCV infection
|
1.40 (0.64, 2.98)
|
0.39
|
4.72 (1.34, 18.9)
|
0.016
|
12.4 (2.29, 16.1)
|
0.006
|
22.3 (3.2, 46.2)
|
<0.001
|
||||
|
Preoperative therapy
|
1.33 (0.61, 2.83)
|
0.46
|
3 (0.855, 10.9)
|
0.085
|
3.69 (0.24, 4.15)
|
0.055
|
||||||
|
Tumor size ≥5 cm
|
1.49 (0.71, 3.17)
|
0.29
|
1.43 (0.39, 5.82)
|
0.59
|
1.08 (0.25, 4.77)
|
0.91
|
||||||
|
Multiple tumors
|
0.99 (0.47, 2.1)
|
0.98
|
0.57 (0.14, 2.11)
|
0.4
|
0.79 (0.52, 1.93)
|
0.374
|
||||||
|
Transfusion
|
1.56 (0.2, 3.14)
|
0.48
|
1.98 (0.5, 7.1)
|
0.41
|
1.43 (0.11, 6.57)
|
0.41
|
||||||
|
Operative time ≥418 min
|
2.26 (1.06, 4.96)
|
0.035
|
9.76 (1.76, 18.2)
|
0.006
|
29.2 (2.55, 98.5)
|
0.019
|
7.34 (1.88, 15.2)
|
0.024
|
5.72 (1.29, 10.0)
|
0.017
|
||
|
Blood loss ≥400 ml
|
1.82 (0.86, 3.98)
|
0.12
|
9.78 (1.76, 18.3)
|
0.006
|
7.34 (1.88, 15.2)
|
0.024
|
||||||
Table 4
Univariable and multivariable analysis of clinical factors and morbidity, liver-related morbidity and mortality in patients aged >70 years
|
Clinical factors
|
Morbidity
|
Liver-related morbidity
|
Mortality
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Univariable analysis
|
Multivariable analysis
|
Univariable analysis
|
Multivariable analysis
|
Univariable analysis
|
Multivariable analysis
|
|||||||
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
Hazard ratio
|
P
|
|
|
Sex Male
|
1.89 (0.38, 2.62)
|
0.17
|
1.23 (0.38, 2.6)
|
0.36
|
1.62 (0.48, 2.1)
|
0.49
|
||||||
|
Sarcopenia
|
3.3 (1.99, 11.9)
|
0.046
|
4.6 (1.21, 19.4)
|
0.032
|
8.33 (1.92, 35.4)
|
0.025
|
6.54 (2.6, 27.1)
|
0.011
|
9.7 (1.81, 29.5)
|
0.002
|
6.54 (1.39, 17.3)
|
0.004
|
|
Body mass index ≤22.4 kg/m2
|
0.88 (0.57, 1.76)
|
0.35
|
1.04 (0.19, 5.29)
|
0.96
|
0.69 (0.12, 4.11)
|
0.67
|
||||||
|
Low visceral fat amount
|
0.42 (0.05, 3.25)
|
0.31
|
0.61 (0.02, 8.21)
|
0.64
|
0.95 (0.17 6.22)
|
0.96
|
||||||
|
Albumin ≥4 g/dl
|
1.03 (0.37, 3.99)
|
0.76
|
1.0 (0.11, 2.1)
|
1.0
|
1.0 (0.17, 5.95)
|
1.0
|
||||||
|
Total bilirubin ≥0.7 mg/dl)
|
0.52 (0.04, 5.35)
|
0.51
|
0.35 (0.12, 2.13)
|
0.16
|
0.24 (0.01, 1.67)
|
0.16
|
||||||
|
Platelet count ≥17.1 × 104/μl
|
0.68 (0.22, 3.1)
|
0.38
|
0.31 (0.02, 2.54)
|
0.133
|
0.23 (0.06, 1.91)
|
0.13
|
||||||
|
ICGR15 ≥10.3%
|
0.39 (0.03, 1.56)
|
0.13
|
0.36 (0.02, 1.54)
|
0.133
|
0.22 (0.011, 1.52)
|
0.13
|
||||||
|
HCV infection
|
2.11 (0.42, 2.39)
|
0.15
|
11.2 (1.23, 101)
|
0.009
|
8.23 (3.81, 15.7)
|
0.004
|
11.6 (6.6, 25.1)
|
<0.001
|
8.23 (2.15, 13.9)
|
0.003
|
||
|
Preoperative therapy
|
1.91 (0.55, 6.71)
|
0.31
|
8.25 (1.38, 49.2)
|
0.011
|
4.6 (1.05, 20.4)
|
0.032
|
17.0 (3.77, 36.2)
|
0.004
|
4.6 (1.49, 10.4)
|
0.032
|
||
|
Tumor size ≥5 cm
|
4.15 (1.2, 16.1)
|
0.024
|
5.0 (1.21, 19.4)
|
0.025
|
1.05 (0.18, 6.26)
|
0.96
|
1.05 (0.18, 6.26)
|
0.96
|
||||
|
Multiple tumors
|
1.3 (0.39, 4.32)
|
0.68
|
1.05 (0.18, 6.26)
|
0.69
|
0.95 (0.16, 5.68)
|
0.96
|
||||||
|
Transfusion
|
1.12 (0.09, 11.4)
|
0.36
|
2.04 (0.23, 9.18)
|
0.63
|
1.98 (0.21, 4.88)
|
0.63
|
||||||
|
Operative time ≥421 min
|
1.98 (0.6, 6.8)
|
0.26
|
3.69 (0.15, 6.67)
|
0.055
|
3.69 (0.15, 6.67)
|
0.055
|
||||||
|
Blood loss (ml) ≥400 ml
|
1.69 (0.51, 5.74)
|
0.39
|
7.81 (1.83, 73.2)
|
0.037
|
7.81 (1.83, 73.2)
|
0.037
|
||||||